Zeotech Ltd
ASX:ZEO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zeotech Ltd
ASX:ZEO
|
AU |
|
PharmGen Science Inc
KRX:004720
|
KR |
|
A
|
Aerospace Nanhu Electronic Information Technology Co Ltd
SSE:688552
|
CN |
|
H
|
Heritage Global Inc
NASDAQ:HGBL
|
US |
|
Beijing GeoEnviron Engineering & Technology Inc
SSE:603588
|
CN |
|
T
|
Tokai Holdings Corp
TSE:3167
|
JP |
|
N
|
Ngai Hing Hong Co Ltd
HKEX:1047
|
HK |
|
C
|
Central China Securities Co Ltd
HKEX:1375
|
CN |
Income Statement
Earnings Waterfall
Zeotech Ltd
Income Statement
Zeotech Ltd
| Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue |
0
N/A
|
0
-67%
|
0
+4 400%
|
0
+107%
|
0
-3%
|
0
+27%
|
0
+187%
|
0
+102%
|
0
+30%
|
0
-18%
|
0
-15%
|
0
+122%
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(3)
|
(4)
|
(3)
|
(4)
|
(5)
|
(4)
|
(3)
|
(6)
|
(6)
|
(4)
|
(5)
|
(8)
|
|
| Selling, General & Administrative |
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(4)
|
(3)
|
(6)
|
(6)
|
(3)
|
(4)
|
(6)
|
|
| Research & Development |
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(3)
N/A
|
(4)
-38%
|
(3)
+19%
|
(4)
-37%
|
(5)
-15%
|
(4)
+24%
|
(3)
+7%
|
(6)
-81%
|
(6)
+2%
|
(4)
+41%
|
(5)
-45%
|
(8)
-45%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Pre-Tax Income |
(3)
N/A
|
(4)
-37%
|
(3)
+22%
|
(3)
-19%
|
(4)
-22%
|
(3)
+36%
|
(2)
+9%
|
(6)
-127%
|
(6)
+1%
|
(3)
+49%
|
(4)
-57%
|
(7)
-48%
|
|
| Net Income | |||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(3)
|
(4)
|
(3)
|
(3)
|
(4)
|
(3)
|
(2)
|
(6)
|
(6)
|
(3)
|
(4)
|
(7)
|
|
| Net Income (Common) |
(3)
N/A
|
(4)
-37%
|
(3)
+22%
|
(3)
-19%
|
(4)
-22%
|
(3)
+36%
|
(2)
+9%
|
(6)
-127%
|
(6)
+1%
|
(3)
+49%
|
(4)
-57%
|
(7)
-48%
|
|
| EPS (Diluted) |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|